Immunovative Clinical Research   Report issue

For profit Phase 2
Founded: Carlsbad CA United States (2009)

Organization Overview

First Clinical Trial
2014
NCT02018419
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now